Axsome Therapeutics, Inc.
Member Type
Associate
Organization Type
Manufacturer
Description
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. Axsome delivers scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Its industry-leading neuroscience portfolio includes FDA-approved treatments for agitation associated with dementia due to Alzheimer’s disease, major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit www.axsome.com and follow on LinkedIn and X or contact Trade@axsome.com.
Contact Information
One World Trade Center, 22nd Floor
New York, NY 10007
http://www.axsome.com(866)496-2976
- of 1